Liver disease in children with cystic fibrosis: US-biochemical comparison in 195 patients.

PURPOSE To determine if abnormal liver architecture at ultrasonography (US) is related to abnormal function in children with cystic fibrosis (CF). MATERIALS AND METHODS For 1 year, all 195 children (112 boys, 83 girls; mean age, 8.5 years) attending a CF clinic underwent abdominal US and a standard set of liver function tests. Aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyltransferase levels were analyzed. US signs were interpreted as follows: hypoechogenicity with prominent portal tracks as edema, hyperechogenicity as steatosis, and increased attenuation and nodules within or at the edge of the liver as cirrhosis. Signs of portal hypertension also were sought. US signs were compared with liver function test results. RESULTS Liver sonograms were abnormal in 38 children (19%); of these, 24 (63%) had abnormal test results. The 157 children with normal liver architecture had a much lower prevalence of biochemical abnormality (33 patients [21%]; P < or = .001). All eight children with signs of portal hypertension had abnormal test results. Fourteen (82%) of 17 children with signs of cirrhosis had abnormal liver function. Eight (57%) of 14 patients with signs of steatosis had abnormal function. Diffuse hypoechogenicity of the liver with prominent portal tracks in 16 patients was associated with abnormal function in only five patients. CONCLUSION The relation between abnormal liver architecture at US and results of three liver function tests in children with CF was significant. The most specific US abnormalities related to abnormal function are signs suggestive of portal hypertension and cirrhosis.

[1]  S. Qualman,et al.  Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria? , 1997, Journal of pediatric gastroenterology and nutrition.

[2]  B. Wood.  Cystic fibrosis: 1997. , 1997, Radiology.

[3]  S. Williams,et al.  An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis. , 1995, Journal of hepatology.

[4]  S. Weinberger.  Recent Advances in Pulmonary Medicine , 1993 .

[5]  J. Navarro,et al.  Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up. , 1993, Archives of disease in childhood.

[6]  F. Collins,et al.  Cystic fibrosis: molecular biology and therapeutic implications. , 1992, Science.

[7]  M. Keogan,et al.  Biliary complications of cystic fibrosis. , 1992, Gut.

[8]  P. Davis.  Cystic fibrosis from bench to bedside. , 1991, The New England journal of medicine.

[9]  J. Riordan,et al.  Identification of the Cystic Fibrosis Gene : Chromosome Walking and Jumping Author ( s ) : , 2008 .

[10]  L. Garel,et al.  Biliary disease in cystic fibrosis. , 1988, The New England journal of medicine.

[11]  K. Gaskin,et al.  Liver disease and common-bile-duct stenosis in cystic fibrosis. , 1988, The New England journal of medicine.

[12]  M. Lafortune,et al.  Duplex Doppler examination in portal hypertension: technique and anatomy. , 1987, AJR. American journal of roentgenology.

[13]  W. Berdon,et al.  Gastrointestinal manifestations of cystic fibrosis. , 1987, Seminars in roentgenology.

[14]  J. McHugo,et al.  Ultrasound findings in children with cystic fibrosis. , 1987, The British journal of radiology.

[15]  B. Strandvik,et al.  Morphological findings in the liver of children with cystic fibrosis: A light and electron microscopical study , 1986, Hepatology.

[16]  C. Riely,et al.  Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. , 1986, Radiology.

[17]  R. Brown,et al.  Ultrasonography of the pancreas, liver, and biliary system in cystic fibrosis. , 1984, Archives of disease in childhood.

[18]  C. Henschke,et al.  The hyperechogenic liver in children: cause and sonographic appearance. , 1982, AJR. American journal of roentgenology.

[19]  M. Knowles,et al.  Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. , 1981, The New England journal of medicine.

[20]  R. Churchill,et al.  Computed Tomography in the Evaluation of Liver Disease in Cystic Fibrosis Patients , 1980, Journal of computer assisted tomography.

[21]  T. Boat,et al.  Symptomatic hepatic disease in cystic fibrosis: incidence, course, and outcome of portal systemic hunting. , 1976, Gastroenterology.

[22]  H. Shwachman,et al.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. , 1958, A.M.A. journal of diseases of children.

[23]  H. Shwachman,et al.  The pathological changes in the liver in cystic fibrosis of the pancreas. , 1957, A.M.A. journal of diseases of children.

[24]  K J Parker,et al.  In-vivo measurements of ultrasound attenuation in normal or diseased liver. , 1988, Ultrasound in medicine & biology.

[25]  A. Manhire,et al.  Cystic fibrosis: ultrasonographic findings in the pancreas and hepatobiliary system correlated with clinical data and pathology. , 1985, Clinical radiology.

[26]  Esterly,et al.  Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases. , 1975, Perspectives in pediatric pathology.